The HLA-A*0201/DRB1*0101 transgenic, H-2 class I/class II KO mice used during this 1 study [12] were housed in the animal facilities of the Pasteur Institute. Groups of 6 to 10 2 week-old female mice were primed and then boosted 3 weeks later with the different DNA 3 constructs. Intramuscular nucleic acid immunizations were performed under anesthesia by 4 injecting 100 µg (1 mg/ml) of plasmid DNA into regenerating (i.e. cardiotoxin-treated) 5 tibialis anterior muscles, as previously described [13] . Non-immunized mice served as 6 control for ELISPOT assays. All animal procedures were performed in compliance with 7 approved protocols and guidelines for the proper use and care of laboratory animals. 8 9
Pentamer staining 10
Pentameric peptide-HLA class I complexes (pentamers; ProImmune, Oxford, UK) were used 11 according to the manufacturer's instructions. Four µl of PE-labeled pentamer HBs 335-343 12 and allophycocyanin (APC)-labeled pentamer HBs 348-357 per well were added to 1 million 13 splenocytes in round-bottomed 96-well plates and then incubated at room temperature for 10 14 minutes. 4 µl of APC-labeled pentamer HBV core 18-27 were used as a control. The cells 15
were then washed twice with PBS 1X, BSA 1%, Azide 0.01%. Cell surface staining was 16 performed using anti-CD3-PE-Cy7 (clone 145-2C11, Clinisciences SA, Montrouge, France), 17
anti-CD8-PerCP (clone 53-6.7, BD Biosciences), anti-CD4-PE or -FITC (clone GK1.5, BD 18 Biosciences), and a viability marker (LIVE/DEAD fixable near-IR dead cell stain kit, 19
Invitrogen, France). The cells were incubated for 30 minutes at 4°C, washed again and fixed 20 with 1% paraformaldehyde. At least 250,000 lymphocyte-gated events were acquired on a 21
FACSCanto flow cytometer (BD Biosciences) and analyzed with FlowJo software (Tree star, 22
Inc., Ashland, Or, USA). Values were considered to be positive when at least 15 pentamer-23 positive CD3+CD8+ T cells were counted, corresponding to 0.2% of CD3+CD8+ T cells, and 24 if this percentage was at least twice the percentage obtained with pentamer HBV core 18-27 1 staining. 2 3
IFN-γ and IL-2 ELISPOT assays 4
IFN-γ-and IL-2-producing T cells amongst the splenocytes were quantified by ELISPOT 5 after peptide stimulation for 24 hours, as previously described [14] . Briefly, sterile 6 nitrocellulose MSIP 96-well plates (Millipore, Bedford, MA) were pre-wetted for 1 minute 7 with 15 µL 35% ethanol, washed with water and coated with 50 µl mouse IFN-γ mAb (R4-8 6A2; 5 µg/ml; BD Bioscience) or 50 µl mouse IL-2 mAb (1A12; 5 µg/ml; Mabtech 9 AB, Stockholm, Sweden) in 0.1 M bicarbonate buffer (pH 9.6) overnight at 4°C. Freshly 10 isolated splenocytes were incubated with individual peptides at 2 µg/ml in complete α-MEM 11 medium [14] . Wells containing cells in culture medium were used as negative controls to 12 determine background levels. A Bioreader 4000 (BioSys) counter was used to score the 13 number of spots. Each cell population was titrated in triplicate. The response was considered 14 positive if the median number of spot-forming cells (SFC) in triplicate wells was at least 15 twice that observed in control wells containing medium, and at least 20 SFC per million 16 splenocytes were detected after background subtraction. 17 18
Intracellular staining 19
For CD107a and IFN-γ co-staining, 1 million splenocytes were incubated in the presence of 20 anti-CD107a-FITC (clone 1D4B, BD Biosciences), monensin (2 µg/ml, Clinisciences SA), 21 brefeldin A (5 µg/ml, Sigma), CD28 (1 µg/ml, clone 37-51, BD Biosciences), CD49d (1 22 µg/ml, clone R1.2, BD Biosciences) and peptide HBs 348-357 or HBs 335-343 (2 µg/ml) or 23 medium for 4 hours at 37°C, under 5% CO2. For TNF-α, IFN-γ and IL-2 staining, 1 million 24 splenocytes were incubated in the presence of brefeldin A (2 µg/ml, Sigma) and T helper 25 peptides (2 µg/ml) or medium for 4 hours at 37°C, under 5% CO2. After washing, the cells 1 were incubated with the viability marker, anti-mouse CD8- PerCP-, CD4-PE-or CD4-APC-2   H7-and CD3-PE-Cy7-or APC-(clone 145- Correlations between CD4+ and CD8+ T cell responses were analyzed using the Pearson's 5 correlation coefficient (r). 6 7 We had previously characterized a HLA-DRB1*0101-restricted epitope in HBV envelope 3 (S238, [8] ) and a promiscuous epitope in HBx protein that is able to bind (amongst others) the 4 HLA-DRB1*0101 molecule (X26, [7] ). As a reference T helper epitope we used PADRE that 5 had previously been designed as a universal T helper epitope [11] , for which the immune 6 response is well documented. To evaluate the efficiency of these T helper epitopes in 335-343 [15, 16] and HBs 348-357 [15, 17] (Fig. 1A) . In three other constructs, synthetic 14 codon optimized cDNAs encoding PADRE, X26 or S238 T helper epitopes were inserted in 15 frame downstream of aa 82 of the Ii chain in order to improve their transport to the 16 endoplasmic reticulum, and their association and presentation by MHC class II molecules. 17
The T helper epitopes were thus upstream of the region encoding the HLA-A2-reporter 18 epitopes. We refer to the vectors carrying these CD4+ epitopes as T helper constructs (Fig.  19   1B) . 20 21
Ex vivo detection of HBs 348-357-and HBs 335-343-specific CD8+ T cells in mice 22
immunized with the pIC constructs. 23
To determine the ability of the selected DRB1*0101 epitopes to provide help in the CD8+ T 24 cell response specific to the reporter epitopes, transgenic mice expressing human HLA-25 A*0201 and HLA-DRB1*0101 but deficient in H-2 class I and II molecules were immunized 1 twice with T helper versus empty constructs via the intramuscular route. To enable 2 immunological assays, spleen cells were harvested 10 days after the second injection. The 3 number of circulating peptide-specific CD8+ T cells was quantified by pentamer staining, 4 which enables the detection of specific T cells regardless of the cytokine produced. 5
Pentamer HBs 348-357-positive CD8+ T cells were found in mice immunized with pIC-6 PADRE, pIC-X26, pIC-S238 and pIC-Empty (Fig.2A) . The number of mice with pentamer-7 positive T cells (responder mice) was significantly lower (4/22 tested) amongst those 8 immunized with the pIC-Empty vector compared with mice immunized with T helper 9 constructs (p< 0.0001). The number of responder mice was significantly higher in pIC-10 PADRE-and pIC-S238-immunized groups compared with pIC-X26 (Table 1) . 11
Regarding the magnitude of the responses, the percentage of pentamer HBs 348-357-positive 12 CD8+ T cells did not differ significantly between responder mice immunized with T helper 13 constructs (Table 1) 
Activation of IFN-γ-and IL-2-secreting CD8+ T cells in mice immunized with HBV-1 derived T helper epitope constructs. 2
Once the presence of CD8+ T cells specific to the reporter epitopes had been demonstrated, 3 their function was then investigated. Ex vivo ELISPOT assays were used to detect IFN-γ-and 4 IL-2-secreting T cells after overnight stimulation with HBs-derived reporter peptides ( Fig. 3  5 and Fig. 7 ). HBs 348-357 stimulation activated IFN-γ-secreting T cells in spleen cells from 6 mice immunized with pIC-Empty, pIC-PADRE, pIC-X26 and pIC-S238 (Fig. 3 A) . While the 7 number of responder mice was not significantly different after immunization with the four 8 constructs (Fisher's exact test, Table 1 ), the frequency of IFN-γ-secreting HBs 348-357-9 specific T cells was significantly higher using the pIC-X26 and pIC-S238 vectors than with 10 the vector encoding the reference peptide PADRE or pIC-Empty (see p values on Table 1 
HBs 348-357-specific CD8+ T cells express degranulation marker and are cytotoxic. 22
In order to investigate further the function of the HBs-specific CD8+ T cells, CD107a 23 labeling was performed as a marker of degranulation and cytotoxicity [18] . CD8+ T cells 24 expressing CD107a and IFN-γ were found in mice immunized with pIC-PADRE, pIC-X26 with pIC-S238, pIC-X26 and pIC-PADRE (Fig. 4B) . In addition, cytolytic function of 6 splenocytes was assessed in an in vivo cytotoxic assay. As an example, mice that were 7 immunized with pIC-S238 helper construct efficiently lysed target splenocytes pulsed with 8
peptide HBs 348-357 as reflected by the in vivo clearance of >50% of CFSE int targets by 20h, 9
but not those from the co-transferred population pulsed with the control peptide (CFSE high ) or 10 with the HBs 335-343 peptide (CFSE low ) (see Fig. 4C ). These results show that primed CD8+ 11
T cells specific to HBs 348-357 were functional cytotoxic T cells. 12 13
pIC-PADRE and pIC-S238 induced IFN-γ-, IL-2-and TNF-α-secreting CD4+ T cells 14 specific to the T helper epitopes. 15
In order to analyze the potency of these constructs in activating specific CD4+ T cells, 16 splenocytes from immunized mice were stimulated ex vivo with the helper peptide 17 corresponding to the each construct. The secretion of IFN-γ and IL-2 by specific T cells was 18 assessed by ELISPOT assays, and the phenotype of IFN-γ-producing cells was confirmed by 19 intracellular staining, cell surface labeling and FACS analysis (Fig. 5) . As a control, 20 splenocytes from non-immunized mice and from mice immunized with pIC-Empty were 21 stimulated with PADRE, S238 and X26 epitopes, and as expected, no cytokine secretion was 22 observed (data not shown). 23
Mice immunized with pIC-PADRE and pIC-S238 respectively developed PADRE-specific or 24 S238-specific IFN-γ-and IL-2-secreting T cells (Fig. 5A , 5B and Table 1 ). These cytokines 25 were produced by CD4+ T cells as shown by FACS analysis for a representative mouse 1 immunized with pIC-Padre (Fig. 5C ). By contrast, neither IFN-γ-nor IL-2-secreting X26-2 specific T cells were detected in a total of 24 mice immunized with pIC-X26. After PADRE 3 or S238 peptide stimulation, neither the frequency of responder mice nor the number of IFN-4 γ-secreting T cells differed statistically when mice were immunized with pIC-PADRE or pIC-5 S238 (Fig. 5A) . However, PADRE epitope activated a significantly higher number of IL-2-6 secreting T cells, as measured by the mean of SFC compared with the S238 epitope (p=0.001, 7 Table 1 ). 8
To further investigate the profile of cytokines secreted by PADRE-, S238-and X26-specific T 9 cells, TNF-α production by CD4+ T cells was tested by intracellular staining. Fig. 6 shows 10 that mice immunized with pIC-PADRE and pIC-S238 respectively developed PADRE-11 specific or S238-specific TNF-α-secreting CD4+ T cells ( Table 1 activating T cell responses in vivo differed considerably (see Table 1 non-immunized mice (Fig. 3) . However, in a previous study using similar constructs, the 20 CD8+ T cell response against HLA-A*0201-restricted reporter epitopes had also been higher 21 than expected [20] . The absence of CLIP peptide in the pIC-Empty construct may have 22 generated a larger amount of DRIPs providing peptides for class I loading. Otherwise, recent 23 studies have shown that signals derived from the triggering of TLR ligands can bypass the 24 need for CD4+ T-cell help in the in vivo induction of fully efficient effector and memory 25 CD8+ T cells [26] [27] [28] [29] . Such "helpless" CD8+ T cells may have been generated by the CpG 1 motifs contained in our DNA constructs that are known to trigger TLR9. Importantly, the 2 primed CD8+ T cell response also differed regarding its functionality, depending on the T 3 helper epitope present in the construct used for immunization. Even though the frequency of 4
HBs 348-357-specific CD8+ T cells detected after pentamer staining was not significantly 5 different in responder mice (Fig. 2) , the quality of response measured by cytokine secretion, 6
CD107a degranulation marker and cytotoxicity differed between constructs. For example, 7 comparable percentages of pentamer-positive T cells were found following pIC-PADRE, pIC-8 S238 and pIC-X26 immunization. However, the mean percentage of IFN-γ-secreting-HBs 9 348-357-specific CD8+ T cells with cytotoxic function was higher in pIC-S238-and pIC-10 X26-immunized mice compared with those immunized with pIC-PADRE (Fig. 4B) . 11
Following immunization with pIC-S238 and pIC-PADRE, mice developed CD4+ T cells 12 secreting IFN-γ, TNF-α and IL-2 after stimulation with the cognate peptides ( Fig. 5 and 6) . assays [7] , [11] .
8
The quality of both CD4+ and CD8+ T cell responses is more important than their 9 magnitude to maintaining a low level of persistence or eliminating a virus from the body, as 10 reviewed by Seder et al. [32] . Although, we did not assessed cytokine production in a single 11 assay, we showed here that HBV-derived T helper epitope containing constructs could 12 activate CD8+ and/or CD4+ T cells with multiple functions in mice transgenic for MHC class 13 I and class II molecules. With a PADRE-containing construct, the response mainly focused on 14 the strong activation of CD4+ T cells secreting IFN-γ, IL-2 and TNF-α. PADRE is a synthetic 15 epitope and its sequence has been optimized to ensure efficient binding to numerous HLA DR 16 class II molecules and certain mouse class II alleles [11] . This universal helper epitope has 17 been used in various studies on cancer or infectious diseases in order to improve the specific functionally impaired CD8+ T cell responses [36, 37] . In this setting, the X26-and S238-7 specific CD4+ T cells that were characterized during our study could provide in vivo 8 assistance in the development of anti-viral CD8+ T cell responses. HBx is a regulatory protein 9 that is expressed and required during the initial steps of viral replication. The development of 10 an HBx-specific T helper response in a large number of patients with low viremia has 11 suggested a role for an X26-specific response and an associated CD8+ T-cell response in the 12 control of viral replication [7] . The emergence of mutations affecting epitope recognition 13 during reactivation of a disease supports this hypothesis [7] . The S238 epitope is clearly a 14 good candidate to help with the development of an HBV-specific CD8+ T cell immune 15 response. It has also been shown to activate CD4+ T cells from hepatitis B vaccinated 16 patients [8] 
